MAY 22, 2022 1:00 PM PDT

Gout Medication Helps Hospitalized People with Heart Failure

WRITTEN BY: Ryan Vingum

A research team at the University of Virginia Hospital System found that a regularly-used medication for gout, called colchicine, helped improve the survival rates of hospitalized heart failure patients. Results of the study are published in Clinical Cardiology.

As part of the study, researchers gathered and reviewed medical records for over 1,000 people who were hospitalized at the University of Virginia Medical center between 2011 and 2020. Each person was hospitalized for worsening signs of heart failure. Researchers found that survival rates were higher in people who had received colchicine for a recent episode of gout (97.9%) compared to those who did not receive the drug (93.5%).

Researchers expect their findings could have important ramifications for the care of people with worsening heart failure, including colchicine’s role as a potential treatment. In particular, researchers suggest that these findings highlight the importance of inflammation’s role in heart failure. As a medication with anti-inflammatory mechanisms, colchicine could have a promising role in addressing signs of inflammation present in people with heart failure.

Heart failure is a common and, unfortunately, expensive condition. According to the CDC, heart failure was listed on 13% of death certificates in the U.S in 2018, representing about 379,000 people.  A chronic condition, heart failure generally refers to the reduced ability of the heart to pump blood effectively. Many conditions cause heart failure, including coronary artery disease, hypertension, and diabetes.  

Gout and heart failure are also common comorbidities. In fact, gout can increase the risk of someone developing heart failure. Many treatments used to treat heart failure, such as diuretics, can also increase the risk of gout. Diuretics impact the amount of uric acid in the blood. This uric acid can form deposits that in turn causes inflammation known as gout. 

Colchicine works by reducing this inflammation. More research is needed to understand colchicine’s role as a potential heart failure treatment.

Sources: Science Daily; Clinical Cardiology; CDC

About the Author
Professional Writing
Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
OCT 21, 2022
Health & Medicine
How The Brain Processes Sensory Information from Internal Organs
OCT 21, 2022
How The Brain Processes Sensory Information from Internal Organs
A study published in Nature provides insight into how the brain processes sensory information from the internal organs. ...
NOV 09, 2022
Drug Discovery & Development
Neanderthal Genes Risk Causing Toxicity with Common Drugs
NOV 09, 2022
Neanderthal Genes Risk Causing Toxicity with Common Drugs
While the Neandertals have gone extinct, their DNA still lingers in the genome of modern humans, where it can help or ha ...
NOV 15, 2022
Genetics & Genomics
Revealing the Mutations that Make Melanoma Immortal
NOV 15, 2022
Revealing the Mutations that Make Melanoma Immortal
Telomeres cap the ends of chromosomes, preventing breakage. Some cancer cells can use those protective caps to their adv ...
NOV 16, 2022
Health & Medicine
C360 Psilocybin Lessens Treatment-Resistant Depression Symptoms
NOV 16, 2022
C360 Psilocybin Lessens Treatment-Resistant Depression Symptoms
Researchers found that psilocybin may have potential as a treatment for those suffering from extreme depression. Psilocy ...
DEC 01, 2022
Genetics & Genomics
No more manual library preps!
DEC 01, 2022
No more manual library preps!
BioQuleTM NGS System - Say ‘goodbye’ to manual library prepping and ‘hello’ to generating librar ...
NOV 30, 2022
Drug Discovery & Development
Saying "Bye" to UTI E. Coli
NOV 30, 2022
Saying "Bye" to UTI E. Coli
In the arms race between animal and bacteria, endogenous antimicrobial peptides (AMPs) are our body’s way of defen ...
Loading Comments...